Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 4, 2004, Pages 936-942

  Gardulf, Ann ^a,f   Nicolay, Uwe ^o   Math, Dipl ^a   Asensio, Oscar ^b   Bernatowska, Ewa ^c   Böck, Andreas ^d   Costa Carvalho, Beatriz T ^e   Granert, Carl ^f   Haag, Stefan ^g   Hernández, Dolores ^h   Kiessling, Peter ^g   Kus, Jan ⁱ   Matamoros, Nuria ^j   Niehues, Tim ^k   Schmidt, Sigune ^l   Schulze, Ilka ^m   Borte, Michael ⁿ  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Sabadell   (Spain)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d Universitätsklinik für Kinder und Jugendheilkunde   (Austria)

^e Department of Pediatrics

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g ZLB Behring GmbH   (Germany)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁱ NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^l UNIVERSITY OF FREIBURG   (Germany)

^m HUMBOLDT UNIVERSITY   (Germany)

ⁿ UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^o NONE

more..

Author keywords

home care; intravenous IgG therapy; nursing; patient satisfaction; Primary immunodeficiencies; quality of life; self care; subcutaneous IgG therapy

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; EMOTIONAL STRESS; FAMILY; FEMALE; HOME; HOSPITAL; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOTHERAPY; INDEPENDENCE; MALE; MENTAL HEALTH; PARENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL; SELF REPORT; SOCIAL STATUS; SUBSTITUTION THERAPY; TIME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; QUALITY OF LIFE; SELF ADMINISTRATION;

EID: 4944262622     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.06.053     Document Type: Article

References (29)

1. F.S. Rosen, M. Eibl, C. Roifman, A. Fischer, J. Volanakis, and F. Aiuti Primary immunodeficiency diseases. Report of an IUIS scientific committee Clin Exp Immunol 118 suppl 1 1999 1 28
2. A. Gardulf, L. Hammarström, and C.I.E. Smith Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion Lancet 338 1991 162 166
3. A. Gardulf, V. Andersen, J. Björkander, D. Ericson, S.S. Frøland, and R. Gustafson Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs Lancet 345 1995 365 369
4. T.G. Abrahamsen, H. Sandersen, and A. Bustnes Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies Pediatrics 98 1996 1127 1131
5. J. Gaspar, B. Gerritsen, and A. Jones Immunoglobulin replacement therapy by rapid subcutaneous infusions Arch Dis Child 79 1998 48 51
6. M.J. Thomas, V.M. Brennan, and H.M. Chapel Rapid subcutaneous immunoglobulin infusions in children Lancet 342 1993 1432 1433
7. H.M. Chapel, G.P. Spickett, D. Ericson, W. Engl, M. Eibl, and J. Björkander The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy J Clin Immunol 20 2000 94 100
8. S. Hansen, R. Gustafson, C.I.E. Smith, and A. Gardulf Subcutaneous IgG infusions in patients with primary antibody deficiencies: decreased time of delivery with maintained safety Clin Immunol 104 2002 237 241
9. R. Gustafson, A. Gardulf, C. Granert, S. Hansen, and L. Hammarström Prophylactic therapy for selective IgA deficiency Lancet 350 1997 865
10. S. Radinsky, and V.R. Bonagura Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin J Allergy Clin Immunol 112 2003 630 633
11. A. Gardulf, H. Björvell, R. Gustafson, L. Hammarström, and C.I.E. Smith The life situation of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions Clin Exp Immunol 92 1993 200 204
12. J. Landgraf, L. Abetz, and J.E. Ware Jr. The Child Health Questionnaire (CHQ), a user's manual 2nd ed. 1999 The Health Institute Boston
13. J.E. Ware, and C.D. Sherbourne The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473 483
14. J.E. Ware, K.K. Snow, and M. Kosinski SF-36® health survey: manual and interpretation guide 2000 QualityMetric Inc Lincoln (RI)
15. P.B. Daly, J.H. Evans, R.H. Kobayashi, A.L. Kobayashi, H.D. Ochs, and S.H. Fischer Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions Ann Allergy 67 1991 504 510
16. C. Acquardo, B. Jambon, D. Ellis, and P. Marquis Language and translation issues B. Spilker Quality of life and pharmacoeconomics in clinical trials 2nd ed. 1996 Lippincott-Raven Philadelphia 575 585
17. D.L. Fairclough Design and analysis of quality of life studies in clinical trials. Interdisciplinary statistics 2002 Chapman & Hall/CRC Boca Raton (FL)
18. H. Brown, and R. Prescott Applied mixed models in medicine 1999 John Wiley & Sons Ltd New York
19. P.M. Fayers, and D. Machin Quality of life. Assessment, analysis and interpretation 2000 John Wiley & Sons Ltd Chichester
20. R.T. Andersson, N.K. Aaronson, and D. Wilkin Critical review of the international assessments of health-related quality of life Qual Life Res 2 1993 369 395
21. J. Waniewski, A. Gardulf, and L. Hammarström Bioavailability of gamma-globulin after subcutaneous infusions in patients with common variable immunodeficiency J Clin Immunol 14 1994 90 97
22. R. Gustafson, and L. Hammarström Subcutaneous immunoglobulin replacement therapy Ellipse 18 2002 45 48
23. A. Gardulf, H. Björvell, V. Andersen, J. Björkander, D. Ericson, and S. Frøland Lifelong treatment with gammaglobulin to patients with primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy J Adv Nurs 21 1995 917 927
24. Editorial. Hypogammaglobulinemia, fifty years later Clin Immunol 104 2002 201 203
25. A. Gardulf, G. Möller, and E. Jonsson A comparison of the patient-borne costs of therapy with gammaglobulin given at the hospital or at home Int J Technol Assess Health Care 11 1995 345 353
26. Note for guidance on the clinical investigation of human normal immunoglobulin for intravenous administration (IVIg) (CPMP/BPWG/388/95 rev. 1). The European Agency for the Evaluation of Medical Products; Human Medicines Evaluation Unit. Committee for Proprietary Medicinal Products, 1999.
27. Note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use (CPMP/BPWG/283/00). The European Agency for the Evaluation of Medical Products; Human Medicines Evaluation Unit. Committee for Proprietary Medicinal Products, 2002 (operation date 2003).
28. V. Brennan, and H.M. Chapel UK register of patients on home intravenous immunoglobulin therapy Immunodeficiency 4 1993 79 80
29. K. Henderson Training and support to enable home therapy immunoglobulin therapy Nurs Times 99 2003 28 31